ReviewGenes & diseases2023

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy.

Peng Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.